Phoebe Joy Ho, Hang Quach, Sosana Delimpasi, Armando Santoro, Cindy H-S Lee, Nicolas Kint, Sylvia Faict, Yanke Yu, Olivier Catalani, Ameet Mishra, Tulika Tyagi, Clare Devlin, Semira Sheikh, Meletios Dimopoulos. "Subcutaneous cevostamab demonstrates manageable safety and clinically meaningful activity in Relapsed/Refractory multiple myeloma (RRMM): First results from the Phase Ib CAMMA 3 study." Blood, 2025. doi:10.1182/blood-2025-700